Medigene Correlations
| MDGEFDelisted Stock | USD 2.59 0.00 0.00% |
The current 90-days correlation between Medigene AG and Oxford BioDynamics Plc is 0.02 (i.e., Significant diversification). The correlation of Medigene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Medigene Correlation With Market
Good diversification
The correlation between Medigene AG and DJI is -0.16 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Medigene AG and DJI in the same portfolio, assuming nothing else is changed.
Medigene |
The ability to find closely correlated positions to Medigene could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medigene when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medigene - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medigene AG to buy it.
Moving against Medigene Pink Sheet
| 0.58 | SLF | Sun Life Financial | PairCorr |
| 0.53 | BAC | Bank of America Fiscal Year End 10th of January 2025 | PairCorr |
| 0.4 | ROCL | Roth CH Acquisition | PairCorr |
| 0.38 | AVTE | Aerovate Therapeutics | PairCorr |
| 0.61 | DIS | Walt Disney | PairCorr |
| 0.58 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.56 | WMT | Walmart | PairCorr |
| 0.55 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
| 0.54 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
| 0.53 | HD | Home Depot | PairCorr |
| 0.52 | JPM | JPMorgan Chase Fiscal Year End 10th of January 2025 | PairCorr |
| 0.49 | T | ATT Inc Fiscal Year End 22nd of January 2025 | PairCorr |
| 0.45 | CSCO | Cisco Systems | PairCorr |
| 0.39 | PYPL | PayPal Holdings | PairCorr |
| 0.36 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Medigene Pink Sheet performing well and Medigene Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Medigene's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| GMDA | 3.41 | 0.07 | 0.00 | 0.06 | 0.00 | 6.81 | 28.30 | |||
| NWBO | 2.78 | (0.03) | (0.02) | 0.04 | 2.89 | 6.67 | 22.79 | |||
| CTIC | 3.53 | 1.63 | 0.60 | (1.40) | 0.91 | 5.30 | 85.60 | |||
| GERN | 2.02 | (0.22) | 0.00 | (0.21) | 0.00 | 4.12 | 14.00 | |||
| APTCF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| OXBOF | 5.20 | (2.86) | 0.00 | (1.32) | 0.00 | 0.00 | 66.38 | |||
| GTHR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| QRON | 0.63 | (0.08) | 0.00 | (0.35) | 0.00 | 0.00 | 15.79 | |||
| CRPOF | 123.42 | 54.20 | 8.56 | 0.78 | 0.00 | 10.53 | 4,159 | |||
| OTLC | 6.30 | (0.41) | 0.00 | (0.18) | 0.00 | 25.00 | 83.33 |
Medigene Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Medigene pink sheet to make a market-neutral strategy. Peer analysis of Medigene could also be used in its relative valuation, which is a method of valuing Medigene by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Medigene Corporate Management
| Dolores Schendel | Member of the Executive Board, Chief Scientific officer | Profile | |
| Birger Kohlert | Chief Officer | Profile | |
| ErnstLudwig Winnacker | Member of the Supervisory Board | Profile | |
| MBBS BS | CEO Board | Profile | |
| Rene Goedkoop | Acting Officer | Profile |
Still Interested in Medigene AG?
Investing in delisted pink sheets can be risky, as the pink sheet is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.